14573-24-1

Basic information

• Product Name: 3-(2,6-DICHLORO-PHENYL)-PROPAN-1-OL
• Synonyms: 3-(2,6-DICHLORO-PHENYL)-PROPAN-1-OL;2,6-dichlorobenzenepropanol
• CAS NO: 14573-24-1
• Molecular Formula: C₉H₁₀Cl₂O
• Molecular Weight: 205.0811
• Mol File: 14573-24-1.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 301.977°C at 760 mmHg
• Flash Point: 124.029°C
• Appearance: /
• Density: 1.28g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.56
• PKA: 14.94±0.10(Predicted)
• CAS DataBase Reference: 3-(2,6-DICHLORO-PHENYL)-PROPAN-1-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2,6-DICHLORO-PHENYL)-PROPAN-1-OL(14573-24-1)
• EPA Substance Registry System: 3-(2,6-DICHLORO-PHENYL)-PROPAN-1-OL(14573-24-1)

Safety Data

• Hazardous Substances Data: 14573-24-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H10Cl2O/c10-8-4-1-5-9(11)7(8)3-2-6-12/h1,4-5,12H,2-3,6H2

Upstream product

• 75-21-8 oxirane 
• 2014-83-7 1,3-Dichloro-2-chloromethyl-benzene 
• 59507-30-1 ethyl (E)-3-(2,6-dichlorophenyl)prop-2-enoate 
• 20595-49-7 (2E)-3-(2,6-dichlorophenyl)prop-2-enoic acid 
• 1734-77-6 ethyl 2,6-dichlorocinnamate 
• 51656-68-9 3-(2,6-dichlorophenyl)propionic acid 
• 108-23-6 isopropyl chloroformate 

Downstream Products

• 14573-25-2 2-(3-bromopropyl)-1,3-dichlorobenzene 
• 639822-12-1 3-(2,6-dichlorophenyl)-1-propanol methanesulfonate 
• 1057670-91-3 3-(2,6-dichlorophenyl)propionaldehyde 
• 845723-46-8 2-[3-(2,6-dichlorophenyl)propyl]isoindole-1,3-dione 

Relevant articles and documents

FARNESOID X RECEPTOR AGONISTS

The present invention provides novel substituted isoxazole compounds, pharmaceutical compositions, therapeutic uses and processes for preparing the same.

Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor

The present invention relates to a nitrogen-containing fused ring compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, and an anti-HIV agent containing such compound. The compound of the present invention has an HIV integrase inhibitory activity, and is useful as an agent for the prophylaxis or treatment of AIDS, or as an anti-HIV agent. In addition, by the combined use with other anti-HIV agents such as a protease inhibitor, a reverse transcriptase inhibitor and the like, it can be a more effective anti-HIV agent. Becuae it shows integrase-specific high inhibitory activity, the compound can be a pharmaceutical agent safe on human body, which causes only a fewer side effects.